ニュージャージーにおける卵巣がんの臨床試験
ニュージャージー内の拠点で、卵巣がんに関する40件の研究が参加者を募集しています。
ニュージャージー内の都市
公式研究テキスト(英語)
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
- 他1件
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/10/05更新 · NCT07001748Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Hunterdon Medical Center, Flemington
- Monmouth Medical Center Southern Campus, Lakewood
- Cooperman Barnabas Medical Center, Livingston
- 他6件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/05更新 · NCT05564377A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- START New Jersey, East Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06270706A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- John Theurer Cancer Center at Hackensack UMC, Hackensack
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
- Holy Name Medical Center /ID# 279017, Teaneck
被験者募集中第2相
18歳以上 · 女性 · 2026/10/01更新 · NCT07024784A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, New Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/29更新 · NCT05877599A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- John Theurer Cancer Center /ID# 275756, Hackensack
- Rutgers Cancer Institute of New Jersey /ID# 274358, New Brunswick
- Holy Name Medical Center /ID# 276240, Teaneck
被験者募集中第2相
18歳以上 · 女性 · 2026/09/29更新 · NCT06890338Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, East Brunswick
被験者募集中第2相
18歳〜130歳 · 全性別 · 2026/09/23更新 · NCT05489211A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Md Anderson Cancer Center At Cooper /ID# 278390, Camden
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07059845Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Maimonides Medical Center, Short Hills
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627A Study of Isoquercetin in People With Ovarian Cancer
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities), Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07303894ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Astera Cancer Care, East Brunswick
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/14更新 · NCT05059444FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
- START New Jersey East Brunswick, East Brunswick
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT06303505Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- START - New Jersey, East Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06293898A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0081), Hackensack
- Rutgers Cancer Institute of New Jersey ( Site 0071), New Brunswick
被験者募集中第3相
18歳以上 · 女性 · 2026/09/03更新 · NCT06824467Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
- Start Njeb, East Brunswick
被験者募集中第1/2相
18歳以上 · 女性 · 2026/09/01更新 · NCT07736937Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack
被験者募集中第1相
15歳以上 · 全性別 · 2026/08/25更新 · NCT06276491A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/21更新 · NCT06774963A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
- Normunity Investigational Site, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/18更新 · NCT07182149A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- John Theurer Cancer Center, Hackensack
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/17更新 · NCT04895709A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Site 0111, Camden
被験者募集中第3相
18歳以上 · 女性 · 2026/08/12更新 · NCT07546500A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Cooper Hospital University Medical Center, Camden
- Jersey City Medical Center, Jersey City
- 他12件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Summit Medical Group, Berkeley Heights
- Cooper Hospital University Medical Center, Camden
- 他9件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/05更新 · NCT07444814Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- MD Anderson Cancer Center at Cooper- Two Cooper Plaza, Camden
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- Valley Health System, Paramus
- Holy Name, Teaneck
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06161025A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
被験者募集中第2相
8歳以上 · 全性別 · 2026/07/27更新 · NCT05503797Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Valley Health System, Paramus
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
被験者募集中
18歳以上 · 女性 · 2026/07/01更新 · NCT05429970A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib Study
- GSK Investigational Site, Morristown
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/24更新 · NCT04641247Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk Women
- Carol G. Simon Cancer Center / Atlantic Health, Morristown
被験者募集中健康なボランティア歓迎
50歳〜74歳 · 女性 · 2026/05/06更新 · NCT00539162Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
- Holy Name Medical Center, Teaneck
被験者募集中第3相
18歳以上 · 女性 · 2026/04/16更新 · NCT05659381Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery
- Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/01更新 · NCT06290193A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- Hackensack University Medical Center, Hackensack
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/13更新 · NCT06778863A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer
- Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
- Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/11更新 · NCT06623396A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
- John Theurer Cancer Center Hackensack University Medical Center, Hackensack
被験者募集中第1相
18歳以上 · 女性 · 2026/02/03更新 · NCT06469281CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
- Rutgers Cancer Institute, New Brunswick
被験者募集中第2相
18歳以上 · 女性 · 2025/12/23更新 · NCT06690775SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
- Exelixis Clinical Site #9, New Brunswick
被験者募集中第1相
18歳以上 · 全性別 · 2025/09/05更新 · NCT05932862ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。